• Something wrong with this record ?

The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease

P. Jabandziev, J. Bohosova, T. Pinkasova, L. Kunovsky, O. Slaby, A. Goel

. 2020 ; 26 (7) : 985-993. [pub] 20200618

Language English Country Great Britain

Document type Introductory Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc21026680

Grant support
R01 CA184792 NCI NIH HHS - United States
R01 CA202797 NCI NIH HHS - United States

Prevalence of inflammatory bowel disease (IBD), a chronic inflammatory disorder of the gut, has been on the rise in recent years-not only in the adult population but also especially in pediatric patients. Despite the absence of curative treatments, current therapeutic options are able to achieve long-term remission in a significant proportion of cases. To this end, however, there is a need for biomarkers enabling accurate diagnosis, prognosis, and prediction of response to therapies to facilitate a more individualized approach to pediatric IBD patients. In recent years, evidence has continued to evolve concerning noncoding RNAs (ncRNAs) and their roles as integral factors in key immune-related cellular pathways. Specific deregulation patterns of ncRNAs have been linked to pathogenesis of various diseases, including pediatric IBD. In this article, we provide an overview of current knowledge on ncRNAs, their altered expression profiles in pediatric IBD patients, and how these are emerging as potentially valuable clinical biomarkers as we enter an era of personalized medicine.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026680
003      
CZ-PrNML
005      
20211026132711.0
007      
ta
008      
211013s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ibd/izaa009 $2 doi
035    __
$a (PubMed)32009179
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Jabandziev, Petr $u Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
245    14
$a The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease / $c P. Jabandziev, J. Bohosova, T. Pinkasova, L. Kunovsky, O. Slaby, A. Goel
520    9_
$a Prevalence of inflammatory bowel disease (IBD), a chronic inflammatory disorder of the gut, has been on the rise in recent years-not only in the adult population but also especially in pediatric patients. Despite the absence of curative treatments, current therapeutic options are able to achieve long-term remission in a significant proportion of cases. To this end, however, there is a need for biomarkers enabling accurate diagnosis, prognosis, and prediction of response to therapies to facilitate a more individualized approach to pediatric IBD patients. In recent years, evidence has continued to evolve concerning noncoding RNAs (ncRNAs) and their roles as integral factors in key immune-related cellular pathways. Specific deregulation patterns of ncRNAs have been linked to pathogenesis of various diseases, including pediatric IBD. In this article, we provide an overview of current knowledge on ncRNAs, their altered expression profiles in pediatric IBD patients, and how these are emerging as potentially valuable clinical biomarkers as we enter an era of personalized medicine.
650    _2
$a biologické markery $x analýza $7 D015415
650    _2
$a dítě $7 D002648
650    _2
$a ulcerózní kolitida $x genetika $7 D003093
650    _2
$a Crohnova nemoc $x genetika $7 D003424
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické markery $x genetika $7 D005819
650    _2
$a lidé $7 D006801
650    _2
$a idiopatické střevní záněty $x genetika $7 D015212
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a individualizovaná medicína $x trendy $7 D057285
650    _2
$a nekódující RNA $x analýza $7 D022661
650    _2
$a signální transdukce $x genetika $7 D015398
650    _2
$a transkriptom $7 D059467
655    _2
$a úvodní články $7 D054711
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bohosova, Julia $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Pinkasova, Tereza $u Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Kunovsky, Lumir $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Goel, Ajay $u Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, California, USA
773    0_
$w MED00002243 $t Inflammatory bowel diseases $x 1536-4844 $g Roč. 26, č. 7 (2020), s. 985-993
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32009179 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132718 $b ABA008
999    __
$a ok $b bmc $g 1715424 $s 1147187
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 26 $c 7 $d 985-993 $e 20200618 $i 1536-4844 $m Inflammatory bowel diseases $n Inflamm Bowel Dis $x MED00002243
GRA    __
$a R01 CA184792 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA202797 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Archiving options